Ansell reported $185.2M in EBIT for its first fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Ansell ANN:AU $ 185.2M 40.5M
Australian Pharma API:AU $ 65.62M 38.91M
Cochlear COH:AU $ 162.9M 30.1M
CSL CSL:AU $ 924.6M 1.51B
Estia Health EHE:AU $ 31.75M 11.32M
Fisher Paykel Healthcare FPH:NZ 302.4M 100.7M
GUD GUD:AU $ 48.84M 1.11M
Healius Ltd HLS:AU $ 113.5M 40.9M
Integral Diagnostics Ltd IDX:AU 18.61M 8.64M
Japara Healthcare JHC:AU -15896000 2.75M
Mayne Pharma MYX:AU $ -9166000 9.41M
Nanosonics Ltd NAN:AU $ 8.54M 7.3M
Next Science Ltd NXS:AU -4265930 1.31M
Polynovo Ltd PNV:AU -2311510 213.72K
Ramsay Health Care RHC:AU $ 352.2M 465.3M
Regis Healthcare REG:AU 27.37M 16.65M
ResMed RMD:AU $ 241.64M 18.21M
Sigma Healthcare Ltd SIG:AU 8.64M 6.64M
Somnomed Ltd SOM:AU -1593980 2.34M
Sonic Healthcare SHL:AU $ 930.84M 64.52M